Halozyme Therapeutics reported $102M in Sales Revenues for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Aptinyx Inc APTX:US $ 0 0
Cytokinetics CYTK:US $ 1.15M 54.45M
Immunogen IMGN:US $ 38.08M 10.09M
Intrexon XON:US $ 21.56M 12.02M
IONIS PHARMACEUT IONS:US $ 440M 306.91M
Nektar Therapeutics NKTR:US $ 25.01M 0.09M
Peregrine Pharmaceuticals PPHM:US $ 26.11M 4.64M